Pharmaceutical Executive
As new ICH GCP draft guidelines now require root cause analysis, novel methods for risk analysis and triage must be adopted in drug development.
Clara Heering
Advertisement
Articles by Clara Heering
Advertisement
Latest Updated Articles
What Errors Do We Miss in Clinical Trials?March 8th 2016
Advertisement
Advertisement
Trending on PharmExec
1
New Study Reveals Genetic Predictors for GLP-1 Weight Loss and Side Effects
2
Pharmaceutical Executive Daily: China Approves Amgen's Tarlatamab for Previously Treated Extensive-Stage Small Cell Lung Cancer
3
Shionogi Inc. Awarded $482 Million Contract with U.S. Government to Enhance National Preparedness for Drug-Resistant Bacterial Threats
4
Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement
5